Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TiMIS: Tirofiban vs DAPT in Mild Acute Ischemic Stroke
NCT07095790Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital of Soochow University
- Start
- Aug 2025
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tirofiban in ischemic stroke (2 arms), sponsored by The Second Affiliated Hospital of Soochow University. Primary endpoint: Proportion of excellent functional outcomes (mRS 0-1) at 90 days. Started Aug 2025; status: recruiting.
02
Drugs
tirofiban
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07095790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07095790.